$IMNN
Imunon, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.24
▼-0.80%-$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateImunon, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is IMNN down today? It is at $1.24 (-0.80%), and our scanner flagged it 9 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IMNN spikes, and full due diligence on IMNN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $IMNN 9 times in the last 30 days. Create a free account to track $IMNN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on IMNN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMNN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →The company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
At-the-market (ATM) program — sells new shares into the market gradually over time
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Faller Douglas Vincent Officer | Acquired (grant/award) | +1K 0.02% of company | added 2.7% | 47K | $1K at $1.08 | Oct 9, 26 |
Lindborg Stacy Officer | Acquired (grant/award) | +3K 0.05% of company | added 2.6% | 116K | $3K at $1.08 | Oct 9, 26 |
Tardugno Michael H Officer | Acquired (grant/award) | +8K 0.1% of company | added 7.5% | 112K | $8K at $1.08 | Oct 9, 26 |
Faller Douglas Vincent Officer | Acquired (grant/award) | +4K 0.08% of company | added 11% | 46K | $6K at $1.41 | Sep 25, 26 |
Lindborg Stacy Officer | Acquired (grant/award) | +7K 0.1% of company | added 6.3% | 113K | $9K at $1.41 | Sep 25, 26 |
Tardugno Michael H Officer | Acquired (grant/award) | +7K 0.1% of company | added 7.4% | 104K | $10K at $1.41 | Sep 25, 26 |
Faller Douglas Vincent Officer | Acquired (grant/award) | +4K 0.08% of company | added 11% | 41K | $6K at $1.47 | Sep 11, 26 |
Lindborg Stacy Officer | Acquired (grant/award) | +6K 0.10% of company | added 5.5% | 106K | $8K at $1.47 | Sep 11, 26 |
Tardugno Michael H Officer | Acquired (grant/award) | +6K 0.1% of company | added 6.5% | 96K | $9K at $1.47 | Sep 11, 26 |
Eylward Susan Officer | Sold (automatic/other) | -3K 0.04% of company | sold 47% | 3K | $4K at $1.56 | Aug 31, 26 |
Eylward Susan Officer | Acquired (grant/award) | +3K 0.04% of company | added 87% | 5K | $4K at $1.60 | Aug 28, 26 |
Faller Douglas Vincent Officer | Acquired (grant/award) | +4K 0.06% of company | added 11% | 37K | $6K at $1.60 | Aug 28, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on IMNN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMNN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
IMNN last traded at $1.24, down 0.80% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Imunon, Inc. Common Stock (IMNN) is next expected to report earnings on Thursday, November 12, 2026, about 18 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The IMNN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IMNN 9 times in the last 30 days.
IMNN (Imunon, Inc. Common Stock) trades on XNAS, with a market cap of about $7M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IMNN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IMNN discussion
Sign in to ask a question or join the discussion.